These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12579269)

  • 1. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction.
    Tsuchida A; Nagakawa Y; Kasuya K; Itoi T; Endo M; Ozawa T; Aoki T; Koyanagi Y
    Oncol Rep; 2003; 10(2):339-43. PubMed ID: 12579269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
    Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
    Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
    Wendum D; Boëlle PY; Rigau V; Sebbagh N; Olschwang S; Mourra N; Parc R; Trugnan G; Masliah J; Fléjou JF
    Virchows Arch; 2003 Feb; 442(2):111-7. PubMed ID: 12596060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction.
    Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K
    Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
    Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
    Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
    Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.
    Sennlaub F; Valamanesh F; Vazquez-Tello A; El-Asrar AM; Checchin D; Brault S; Gobeil F; Beauchamp MH; Mwaikambo B; Courtois Y; Geboes K; Varma DR; Lachapelle P; Ong H; Behar-Cohen F; Chemtob S
    Circulation; 2003 Jul; 108(2):198-204. PubMed ID: 12821538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus: long-term follow-up study.
    Ogata Y; Fujita H; Yamana H; Sueyoshi S; Shirouzu K
    World J Surg; 2003 May; 27(5):584-9. PubMed ID: 12715228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
    Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
    Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts.
    Miura S; Tatsuguchi A; Wada K; Takeyama H; Shinji Y; Hiratsuka T; Futagami S; Miyake K; Gudis K; Mizokami Y; Matsuoka T; Sakamoto C
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G444-51. PubMed ID: 15246970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
    Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
    Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
    J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
    von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
    Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
    Lim SC
    Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 expression in the gallbladder of patients with anomalous arrangement of the pancreaticobiliary duct.
    Fumino S; Tokiwa K; Ono S; Iwai N
    J Pediatr Surg; 2003 Apr; 38(4):585-9. PubMed ID: 12677571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
    Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
    Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
    Lim SC; Park SY; Do NY
    Oncol Rep; 2003; 10(5):1073-9. PubMed ID: 12883661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.